A) Stimulation of linear growth
B) Promotion of insulin sensitivity
C) Increase in muscle mass
D) Stimulation of IGF-1 secretion by liver
A) Growth hormone deficiency
B) Precocious puberty
C) Constitutional growth delay
D) Hypothyroidism
A) Serum estrogen levels
B) Serum FSH and LH levels
C) Serum thyroid function tests
D) Serum pregnancy test
A) Insulin
B) Cortisol
C) Growth hormone
D) Thyroid hormone
A) Glucagon
B) Somatostatin
C) Insulin
D) Somatomedin C (IGF-1)
A) Hyperglycemia
B) Aging
C) Obesity
D) Hypoglycemia
A) Nipple stimulation
B) Estrogen administration
C) Dopamine agonists
D) Emotional stress
A) Cushing syndrome
B) Addison's disease
C) Acromegaly
D) Hyperthyroidism
A) High blood glucose levels
B) Low blood calcium levels
C) Growth hormone-releasing hormone (GHRH)
D) Thyroid hormone
A) Prolactinoma
B) Polycystic ovary syndrome (PCOS)
C) Hypothyroidism
D) Hyperprolactinemia due to medication
A) Thyroid stimulating hormone (TSH)
B) Follicle stimulating hormone (FSH)
C) Growth hormone (GH)
D) Antidiuretic hormone (ADH)
A) Regulation of blood pressure
B) Regulation of blood glucose levels
C) Regulation of serum osmolality and water balance
D) Stimulation of muscle growth
A) Central diabetes insipidus
B) Nephrogenic diabetes insipidus
C) Syndrome of inappropriate ADH secretion (SIADH)
D) Hypothyroidism
A) Octreotide
B) Desmopressin
C) Somatostatin
D) Prednisone
A) Prolactin secretion is primarily inhibited by thyrotropin-releasing hormone (TRH).
B) Dopamine has a stronger inhibitory effect on prolactin secretion compared to TRH.
C) Prolactin stimulates ovulation in females by increasing GnRH secretion.
D) Estrogens act as dopamine agonists, inhibiting prolactin secretion.
A) Prednisone
B) Bromocriptine
C) Metformin
D) Levothyroxine